Facebook Twitter LinkedIn
Environmental Clean Technologies
Environmental Clean TechnologiesECT
April 9, 2026

Environmental Clean Technologies (ASX:ECT): PFAS is the “new asbestos” and the bill is coming due

On the 24th of December 2025, Environmental Clean Technologies (ASX:ECT) acquired the patent rights to Flash Joule Heating (FJH) technology for the remediation of PFAS in soil from Rice University. The technology was developed under Professor James Tour, who is widely recognised for pioneering this rapid heating method. ECT intends to deploy FJH to address […]
Read More
Amaero
Amaero3DA
January 21, 2026

Amaero (ASX:3DA) is helping to build the new Arsenal of Democracy

Amaero (ASX:3DA) is an emerging supplier of high-value refractory and titanium spherical powders including niobium C103 and Ti64, most of which are used in defence and aerospace applications. The company has also developed capability in parts manufacture. The company commissioned a commercial plant in Tennessee in 2024. Amaero aims to be the largest and lowest […]
Read More
Weebit Nano signs Texas Instruments
Weebit Nano
December 29, 2025

Weebit Nano (ASX:WBT) signs license deal with Texas Instruments, bags an elephant

Weebit Nano announced it has signed a licensing deal with Texas Instruments (TI), the world’s largest manufacturer of analog semiconductors, which are used in computer chips that deal with analog signals, such as temperature, pressure, sound etc. Analog semiconductors account for about 70% to 80% of TI’s revenues. TI also has an embedded processing division […]
Read More
PhosCo
PhosCoPHO
December 18, 2025

It’s all systems go for PhosCo (ASX:PHO) as it advances its Gasaat Phosphate Project in Tunisia

PhosCo (ASX:PHO) is advancing its Gasaat Phosphate Project in Tunisia with the support of government, local communities, and the European Bank for Reconstruction & Development. The company is well primed to become a cost-competitive, globally significant fertiliser producer, at a time of mounting supply concerns for phosphate, further underscored by its recent inclusion on the […]
Read More
Pharmaceutical Innovation
December 10, 2025

Dimerix Nears a Potential First-in-Class Approval in a High-Value Kidney Disease Market

Accelerated approval pathway for DMX-200 could reshape treatment for FSGS patients Dimerix Ltd (ASX: DXB) is entering what could be the most pivotal phase in its decade-long development journey for DMX-200 (Qytovra®), a drug targeting the rare and devastating kidney disease Focal Segmental Glomerulosclerosis (FSGS). With no approved treatments globally and only five years on […]
Read More
Percheron Therapeutics
PERPercheron Therapeutics
November 27, 2025

Percheron Therapeutics (ASX:PER) has Phase 2 coming in 2026

Percheron Therapeutics (ASX:PER) has one of the most promising oncology assets in HMBD-002. HMBD-002 is an immune-oncology therapy (meaning it utilises a patient’s immune system) that inhibits a pathway called VISTA that plays a key role in suppressing T-cell responses to cancer treatments. Following positive Phase 1 data, Percheron is taking HMBD-002 into Phase 2 […]
Read More
Alma Metals
Alma MetalsALM
November 25, 2025

Alma Metals (ASX:ALM) is riding the copper wave with one of Australia’s largest undeveloped projects

Alma Metals (ASX:ALM) is an advanced exploration-stage company, focused on developing the Briggs Copper JV project in Queensland, in which it has a 51% stake. It can increase this to 70%. Alma Metals has recorded stellar exploration results up to this point and, following a recently completed Scoping Study, has committed to a Preliminary Feasibility […]
Read More
Adisyn Ltd
November 19, 2025

Adisyn Takes a Key Step Forward in Graphene Chip Technology

Validation of a critical manufacturing stage brings Adisyn closer to commercialising next-generation semiconductor interconnects Adisyn Ltd (ASX: AI1) has reached an important technical milestone in the development of its graphene-based semiconductor technology, ticking off a crucial early step on the path toward commercial deployment. Through its IP subsidiary, 2D Generation (2DG), the company has successfully […]
Read More
Edge-AI and Robotics
November 19, 2025

DorsaVi Enters the Neuromorphic Computing Space With High-Value IP Acquisition

New processing-in-memory technology pushes the company toward next-generation robotics and edge-AI applications DorsaVi Ltd (ASX: DVL) has taken a significant strategic step with the acquisition of neuromorphic processing-in-memory (PIM) intellectual property from Technion in Israel — technology led by Professor Shahar Kvatinsky, one of the semiconductor industry’s most prominent neuromorphic hardware researchers. This move positions […]
Read More
Register for the Conference